Kincell Bio Overview
- Year Founded
-
2023
- Status
-
Acquired/Merged
- Employees
-
82
- Latest Deal Type
-
M&A
Kincell Bio General Information
Description
Operator of a contract development and manufacturing organization intended to advance autologous and allogeneic cell therapies for patients. The company streamlines CMC development, applying expertise in analytical and processing development and GMP manufacturing to test and release from early clinical to pivotal studies and product launch, enabling researchers and laboratories to process development and manufacturing from early clinical to pivotal supply and commercial launch, ensuring rapid timelines without compromising on quality.
Contact Information
Website
www.kincellbio.comCorporate Office
- 1622 North West 55th Place
- Gainesville, FL 32653
- United States
Corporate Office
- 1622 North West 55th Place
- Gainesville, FL 32653
- United States
Kincell Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 17-Sep-2026 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 15-May-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 26-Jul-2023 | $36M | $36M | Completed | Generating Revenue | |
| 1. Spin-Off | 01-Jan-2023 | Completed | Startup |
Kincell Bio Signals
Kincell Bio Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Inceptor Bio | VC-Backed Company | |||
| Kineticos Life Sciences Management | Venture Capital | Minority | ||
| NewSpring Capital | Growth/Expansion | Minority |
Kincell Bio Investments (1)
Kincell Bio’s most recent deal was a Corporate Asset Purchase with Imugene (Cell Therapy Manufacturing Facility in North Carolina) for . The deal was made on 16-Apr-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Imugene (Cell Therapy Manufacturing Facility in North Carolina) | 16-Apr-2024 | Corporate Asset Purchase | Buildings and Property |
Kincell Bio FAQs
-
When was Kincell Bio founded?
Kincell Bio was founded in 2023.
-
Where is Kincell Bio headquartered?
Kincell Bio is headquartered in Gainesville, FL.
-
What is the size of Kincell Bio?
Kincell Bio has 82 total employees.
-
What industry is Kincell Bio in?
Kincell Bio’s primary industry is Biotechnology.
-
Is Kincell Bio a private or public company?
Kincell Bio is a Private company.
-
What is Kincell Bio’s current revenue?
The current revenue for Kincell Bio is .
-
How much funding has Kincell Bio raised over time?
Kincell Bio has raised $58M.
-
Who are Kincell Bio’s investors?
Inceptor Bio, Kineticos Life Sciences Management, and NewSpring Capital have invested in Kincell Bio.
-
When was Kincell Bio acquired?
Kincell Bio was acquired on 17-Sep-2026.
-
Who acquired Kincell Bio?
Kincell Bio was acquired by Kincellis Advanced Therapies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process